Novel bioabsorbable, low-dose rate brachytherapy device (CivaSheet®) with radical prostatectomy and adjuvant external beam radiation for the management of prostate cancer

IF 3.7 2区医学 Q1 UROLOGY & NEPHROLOGY

BJU International Pub Date : 2024-12-09 DOI:10.1111/bju.16617

Kennedy E. Okhawere, Shirin Razdan, Alp Tuna Beksac, Indu Saini, Laura Zuluaga, Kirolos Meilika, Burak Ucpinar, Ren-Dih Sheu, Reza Mehrazin, John Sfakianos, Ashutosh Tewari, Richard G. Stock, Ketan Badani

引用次数: 0

Abstract

To investigate the safety and cancer control of a novel bioabsorbable, low-dose rate brachytherapy device, CivaSheet^® (CivaTech Oncology Inc., Durham, NC, USA), in combination with radical prostatectomy (RP) with or without adjuvant external beam radiation therapy (EBRT) for the management of prostate cancer (PCa).

查看原文本刊更多论文

新型生物可吸收，低剂量率近距离放射治疗装置（CivaSheet®）与根治性前列腺切除术和辅助外束放射治疗前列腺癌的管理

研究一种新型生物可吸收、低剂量率近距离放射治疗装置CivaSheet®（CivaTech Oncology Inc., Durham， NC， USA）联合根治性前列腺切除术（RP）加或不加辅助外束放射治疗（EBRT）治疗前列腺癌（PCa）的安全性和癌症控制。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BJU International 医学-泌尿学与肾脏学

CiteScore

9.10

自引率

4.40%

发文量

262

审稿时长

1 months

期刊介绍： BJUI is one of the most highly respected medical journals in the world, with a truly international range of published papers and appeal. Every issue gives invaluable practical information in the form of original articles, reviews, comments, surgical education articles, and translational science articles in the field of urology. BJUI employs topical sections, and is in full colour, making it easier to browse or search for something specific.